SITA TAIBI: Open Payments
NPI 1811327281 · MEDFORD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,148 in 49 payments from 15 companies in 2025. Trend: 2023 $1,108 · 2024 $1,082 · 2025 $1,148
Food & beverage: $1,148
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 8 | $168 |
| AstraZeneca Pharmaceuticals LP | 6 | $135 |
| Novo Nordisk Inc | 6 | $133 |
| ABBVIE INC. | 4 | $115 |
| Amgen Inc. | 4 | $114 |
| PFIZER INC. | 5 | $110 |
| Axsome Therapeutics, Inc. | 3 | $75 |
| Lundbeck LLC | 3 | $70 |
| Astellas Pharma US Inc | 2 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
Products named: REXULTI, SHINGRIX, EVENITY, Auvelity, AIRSUPRA, FARXIGA, TRELEGY ELLIPTA, UBRELVY.
Industry payments across OR — which companies pay providers there.
